Option Care Health Inc
NASDAQ:OPCH
Intrinsic Value
Option Care Health, Inc. engages in the provision of home and alternate site infusion services. [ Read More ]
The intrinsic value of one OPCH stock under the Base Case scenario is 38.98 USD. Compared to the current market price of 29.93 USD, Option Care Health Inc is Undervalued by 23%.
Valuation Backtest
Option Care Health Inc
Run backtest to discover the historical profit from buying and selling OPCH stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Option Care Health Inc
Current Assets | 1.1B |
Cash & Short-Term Investments | 343.8m |
Receivables | 377.7m |
Other Current Assets | 372.7m |
Non-Current Assets | 2.1B |
Long-Term Investments | 20.9m |
PP&E | 204.8m |
Intangibles | 1.9B |
Other Non-Current Assets | 21.4m |
Current Liabilities | 618.3m |
Accounts Payable | 426.5m |
Accrued Liabilities | 185.8m |
Other Current Liabilities | 6m |
Non-Current Liabilities | 1.2B |
Long-Term Debt | 1.1B |
Other Non-Current Liabilities | 120.4m |
Earnings Waterfall
Option Care Health Inc
Revenue
|
4.3B
USD
|
Cost of Revenue
|
-3.3B
USD
|
Gross Profit
|
981.2m
USD
|
Operating Expenses
|
-666.6m
USD
|
Operating Income
|
314.6m
USD
|
Other Expenses
|
-47.5m
USD
|
Net Income
|
267.1m
USD
|
Free Cash Flow Analysis
Option Care Health Inc
OPCH Profitability Score
Profitability Due Diligence
Option Care Health Inc's profitability score is 55/100. The higher the profitability score, the more profitable the company is.
Score
Option Care Health Inc's profitability score is 55/100. The higher the profitability score, the more profitable the company is.
OPCH Solvency Score
Solvency Due Diligence
Option Care Health Inc's solvency score is 50/100. The higher the solvency score, the more solvent the company is.
Score
Option Care Health Inc's solvency score is 50/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
OPCH Price Targets Summary
Option Care Health Inc
According to Wall Street analysts, the average 1-year price target for OPCH is 40.36 USD with a low forecast of 36.36 USD and a high forecast of 45.15 USD.
Ownership
OPCH Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
OPCH Price
Option Care Health Inc
Average Annual Return | 46.57% |
Standard Deviation of Annual Returns | 50.33% |
Max Drawdown | -66% |
Market Capitalization | 5.2B USD |
Shares Outstanding | 173 498 000 |
Percentage of Shares Shorted | 3.46% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Option Care Health, Inc. engages in the provision of home and alternate site infusion services. The company is headquartered in Bannockburn, Illinois and currently employs 5,430 full-time employees. The firm provides a therapy portfolio through its network of approximately 97 full-service pharmacies and 57 stand-alone ambulatory infusion suites. Its infusion services include the clinical management of infusion therapy, nursing support and care coordination. The company contracts with managed care organizations, third-party payers, hospitals, physicians and other referral sources to provide pharmaceuticals and complex compounded solutions to patients for intravenous delivery in the patients’ homes or other nonhospital settings. The company administers a range of therapies and services, including anti-infectives infusion, heart failure, chronic inflammatory disorders, immunoglobulin infusion, bleeding disorders infusion, nutrition support infusion, neurological disorders, women’s health and others. The company also offers nursing platform that include specialty nursing resources to healthcare providers.
Contact
IPO
Employees
Officers
The intrinsic value of one OPCH stock under the Base Case scenario is 38.98 USD.
Compared to the current market price of 29.93 USD, Option Care Health Inc is Undervalued by 23%.